Zobrazeno 1 - 10
of 653
pro vyhledávání: '"Lipids"'
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Abnormalities in serum lipids and lipoproteins have been documented to link to the risk of cancers in recent years, but its prognostic value for cancer is not known. This study retrospectively evaluated the significance of preoperative ser
Autor:
Yu-Chen Chang, Le-Yin Hsu, Chien-Ju Lin, Tzu-Lin Yeh, Kuo-Liong Chien, Hsin-Yin Hsu, Ming-Chieh Tsai
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-10 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Blood lipids are essential components for cellular growth. An inverse association between serum lipid levels and risk of cancer has led to a controversy among previous studies. The aim of this prospective cohort study was to investigate th
Autor:
Zhen-Vin Lee, Elmer Jasper Llanes, Renan Sukmawan, Nuntakorn Thongtang, Huynh Quang Tri Ho, Philip Barter, on behalf of the Cardiovascular RISk Prevention (CRISP) in Asia Network
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-12 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Cardiovascular disease (CVD) is a major cause of mortality and morbidity within the Asia-Pacific region, with the prevalence of CVD risk factors such as plasma lipid disorders increasing in many Asian countries. As members of the Cardiovascular RISk
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Pemafibrate, a selective PPARα modulator, has the beneficial effects on serum triglycerides (TGs) and very low density lipoprotein (VLDL), especially in patients with diabetes mellitus or metabolic syndrome. However, its effect on the low
Autor:
Andrey Sivkov, Svetlana Sivkova, Roman V. Gorenkov, Sergey Sivkov, Natalya P. Chernus, Tamara Savina
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background To determine the effect of genetic polymorphism of drug transporters on the efficacy of treatment with Rosuvastatin, Atorvastatin and Simvastatin in patients with hyperlipidemia. Methods The study consists of 180 patients, aged 40–75 yea
Autor:
Jiacheng Lai, Qingtong Wang, Meili Dong, Bin Li, Jingshu Ni, Yikun Wang, Chongjian Huang, Yongsheng Han
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart disease (CHD), and a variety of indicators are used to evaluate lipid management. This work analyses the
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-10 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly attributed to disease-causing variants in the low-density lipoprotein receptor (LDLR) gene. The aim of this study was to explore the molecular mechanism of LDL
Autor:
Asie Sadeghi, Nasrin Borumandnia, Maryam Teimouri, Nariman Moradi, Mehrdad Karimi, Akram Vatannejad, Asma Kheirollahi
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-9 (2020)
Lipids in Health and Disease
Lipids in Health and Disease
Background Insulin resistance has a vital role in the pathophysiology of polycystic ovary syndrome (PCOS). Previous investigations have shown that some lipid ratios could be a simple clinical indicator of insulin resistance (IR) in some disorders and
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-8 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background About 20–40 % of autistic people experience a phenomenon of regression. Retinol binding protein 4 (RBP4) plays an important role as an inflammatory neurotrophic adipokine and is a promising mediator of the fat-brain axis. Abnormal fatty
Autor:
Cheng Zhang, Liu Lu, Yukai Xiang, Yulong Yang, Xiangyu Kong, Ruiqi Lu, Chuanqi He, Jingli Cai, Bosen Zhang
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-10 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Pancreaticobiliary reflux (PBR) causes chronic inflammation of the gallbladder mucosa and changes in the bile components, which are known to promote gallstone formation. This study aimed to investigate the bile biochemistry changes in gall